Tele-Collaborative Outreach to Rural Patients With Chronic Pain

NCT06091202 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 608

Last updated 2025-07-20

No results posted yet for this study

Summary

This is a randomized controlled trial comparing the effectiveness of a remotely delivered collaborative care intervention for chronic pain versus a minimally enhanced control group. The specific aims of the study are: (1) compare the effectiveness of tele-collaborative pain care vs. minimally enhanced usual care to improve pain interference over 12 months of follow-up, and (2) oversample women and rural veterans of minoritized race/ethnicity to test heterogeneity of treatment effects across birth sex and race/ethnicity.

Conditions

Interventions

BEHAVIORAL

CORPs Intervention

Participants will be randomly assigned to the intervention or to the comparator arm. The follow-up period is 12 months. The primary outcome is a change in pain interference. After the baseline assessment, participants will complete a masked telephone assessments with research staff at 3-, 6-, 9-, and 12-months. A subset of individuals may be invited to participate in a qualitative interview at 12-month follow-up.

BEHAVIORAL

Minimally Enhanced Usual Care (MEUC)

Participants will be randomly assigned to the intervention or to the comparator arm. The follow-up period is 12 months. The primary outcome is a change in pain interference. After the baseline assessment, participants will complete a masked telephone assessments with research staff at 3-, 6-, 9-, and 12-months. A subset of individuals may be invited to participate in a qualitative interview at 12-month follow-up.

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH
  • Portland VA Medical Center

    collaborator FED
  • Minneapolis Veterans Affairs Medical Center

    collaborator FED
  • North Texas Veterans Healthcare System

    collaborator FED
  • VA Tennessee Valley Health Care System

    collaborator FED
  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Travis Lovejoy, PhD, MPH · Oregon Health & Science University, VA Portland Health Care System

  • Benjamin Morasco, PhD · Oregon Health & Science University, VA Portland Health Care System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-11
Primary Completion
2027-05-01
Completion
2027-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06091202 on ClinicalTrials.gov